NFKB1 and atherosclerosis: Collectively, our results demonstrate that MED, a novel marine microbial compound, can inhibit macrophage foam cell formation and activation in vitro and suppress atherosclerosis in ApoE−/− mice, at least in part by inhibiting NF-κB activation.